Skip to main content

ABBV

AbbVie Inc.
Sector
Health Care
Industry
Biotechnology
Last price
$218.31
As of

Active signals for ABBV

Top institutional holders of ABBV (13F)

FundMarket value% portfolioQoQ
MILLENNIUM MANAGEMENT LLC$466.7M0.20%,
CITADEL ADVISORS LLC$437.4M0.07%,
CITADEL ADVISORS LLC$327.4M0.05%-24.2%
RENAISSANCE TECHNOLOGIES LLC$214.9M0.28%,
MILLENNIUM MANAGEMENT LLC$174.5M0.07%+3934.1%
D. E. Shaw & Co., Inc.$153.5M0.08%+12.1%
D. E. Shaw & Co., Inc.$146.4M0.09%+0.2%
D. E. Shaw & Co., Inc.$138.8M0.08%,
Point72 Asset Management, L.P.$83.2M0.14%,
Bridgewater Associates, LP$60.4M0.24%,
Point72 Asset Management, L.P.$6.7M0.01%-91.8%
Bridgewater Associates, LP$6.6M0.03%+113.7%
TWO SIGMA INVESTMENTS, LP$5.1M0.01%+102.7%
TWO SIGMA INVESTMENTS, LP$5M0.00%+3.1%
Point72 Asset Management, L.P.$4.9M0.01%-23.2%
MILLENNIUM MANAGEMENT LLC$4.5M0.00%-99.0%
Bridgewater Associates, LP$3.2M0.01%-94.5%
TWO SIGMA INVESTMENTS, LP$2.5M0.00%,

Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.

Recent SEC filings, ABBV

Related tickers in Health Care

See more ABBV signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Sign in to track ABBV in your watchlist and get notified the moment a new signal fires.

Track ABBV on Kresmion →